Sunil Healthcare Ltd
Incorporated in 1976, Sunil Healthcare Ltd is a manufacturer of Empty Hard Gelatin, HPMC Capsule Shells & Ayurvedic Medicines[1]
- Market Cap ₹ 78.6 Cr.
- Current Price ₹ 76.6
- High / Low ₹ 80.0 / 45.6
- Stock P/E
- Book Value ₹ 58.4
- Dividend Yield 0.00 %
- ROCE 14.7 %
- ROE 11.9 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 8.86% over last 3 years.
- Earnings include an other income of Rs.4.60 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
43.42 | 46.14 | 61.66 | 72.64 | 81.63 | 108.95 | 90.22 | 80.93 | 70.13 | 89.89 | 116.37 | 111.83 | 88.69 | |
35.51 | 38.36 | 50.35 | 60.57 | 66.75 | 93.21 | 75.52 | 68.45 | 76.58 | 83.68 | 98.55 | 92.52 | 84.38 | |
Operating Profit | 7.91 | 7.78 | 11.31 | 12.07 | 14.88 | 15.74 | 14.70 | 12.48 | -6.45 | 6.21 | 17.82 | 19.31 | 4.31 |
OPM % | 18.22% | 16.86% | 18.34% | 16.62% | 18.23% | 14.45% | 16.29% | 15.42% | -9.20% | 6.91% | 15.31% | 17.27% | 4.86% |
0.86 | 1.33 | 0.38 | 0.94 | 1.33 | 1.25 | 2.00 | 0.09 | 14.71 | 5.56 | 1.55 | 1.63 | 4.60 | |
Interest | 2.28 | 3.10 | 2.48 | 2.85 | 4.36 | 4.18 | 5.03 | 6.58 | 6.95 | 5.31 | 3.49 | 4.17 | 5.19 |
Depreciation | 3.21 | 3.82 | 4.09 | 4.00 | 3.82 | 4.33 | 4.78 | 5.74 | 6.13 | 6.11 | 6.31 | 7.01 | 6.65 |
Profit before tax | 3.28 | 2.19 | 5.12 | 6.16 | 8.03 | 8.48 | 6.89 | 0.25 | -4.82 | 0.35 | 9.57 | 9.76 | -2.93 |
Tax % | 33.84% | 33.79% | 35.94% | 35.39% | 34.99% | 33.73% | 22.64% | 28.00% | 13.49% | 22.86% | 29.15% | 28.48% | |
2.17 | 1.44 | 3.28 | 3.98 | 5.23 | 5.62 | 5.32 | 0.18 | -4.17 | 0.28 | 6.78 | 6.98 | -2.20 | |
EPS in Rs | 2.12 | 1.40 | 3.20 | 3.88 | 5.10 | 5.48 | 5.19 | 0.18 | -4.07 | 0.27 | 6.61 | 6.81 | -2.14 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 4% |
3 Years: | 17% |
TTM: | -27% |
Compounded Profit Growth | |
---|---|
10 Years: | 20% |
5 Years: | 5% |
3 Years: | 56% |
TTM: | -120% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 17% |
3 Years: | 26% |
1 Year: | 16% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 4% |
3 Years: | 9% |
Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
Reserves | 8.17 | 9.60 | 12.87 | 15.62 | 20.81 | 33.24 | 38.54 | 38.88 | 37.52 | 37.82 | 44.53 | 51.47 | 49.69 |
Preference Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.76 | 0.87 | 1.00 | 1.15 | |
16.75 | 22.45 | 19.94 | 25.16 | 37.06 | 44.53 | 60.62 | 55.08 | 48.69 | 48.95 | 33.68 | 35.63 | 48.99 | |
11.27 | 11.05 | 12.59 | 12.51 | 17.66 | 31.33 | 33.18 | 35.50 | 37.95 | 26.55 | 23.73 | 28.73 | 27.74 | |
Total Liabilities | 46.44 | 53.35 | 55.65 | 63.54 | 85.78 | 119.35 | 142.59 | 139.71 | 134.41 | 123.57 | 112.19 | 126.08 | 136.67 |
22.56 | 27.47 | 27.02 | 27.31 | 40.94 | 59.72 | 70.92 | 68.82 | 69.97 | 69.80 | 69.97 | 70.43 | 67.04 | |
CWIP | 0.36 | 1.25 | 0.26 | 0.77 | 0.06 | 0.12 | 0.19 | 2.47 | 0.01 | 0.01 | 1.75 | 0.01 | 0.03 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 | 0.24 | 0.24 | 1.20 | 1.16 | 0.00 | 0.00 |
23.52 | 24.63 | 28.37 | 35.46 | 44.78 | 59.51 | 71.25 | 68.18 | 64.19 | 52.56 | 39.31 | 55.64 | 69.60 | |
Total Assets | 46.44 | 53.35 | 55.65 | 63.54 | 85.78 | 119.35 | 142.59 | 139.71 | 134.41 | 123.57 | 112.19 | 126.08 | 136.67 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3.41 | 4.24 | 8.18 | 5.88 | 7.77 | 10.79 | 4.91 | 15.07 | 4.18 | 16.63 | 21.89 | 7.13 | |
-4.03 | -7.64 | -2.72 | -8.48 | -14.90 | -12.85 | -17.36 | -3.08 | -2.46 | -11.33 | -3.35 | -3.40 | |
0.75 | 3.12 | -5.00 | 2.75 | 8.18 | 2.23 | 11.62 | -11.66 | -1.54 | -6.42 | -18.56 | -3.75 | |
Net Cash Flow | 0.13 | -0.28 | 0.46 | 0.15 | 1.05 | 0.17 | -0.83 | 0.33 | 0.18 | -1.12 | -0.01 | -0.02 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 103.48 | 111.38 | 100.04 | 99.39 | 107.94 | 130.49 | 194.11 | 186.63 | 149.01 | 112.84 | 69.00 | 115.90 |
Inventory Days | 143.83 | 198.13 | 132.12 | 109.32 | 134.28 | 74.03 | 98.26 | 185.09 | 283.19 | 95.96 | 76.84 | 97.03 |
Days Payable | 144.33 | 147.76 | 107.06 | 80.62 | 106.03 | 137.66 | 180.38 | 280.22 | 297.33 | 107.97 | 64.07 | 112.06 |
Cash Conversion Cycle | 102.98 | 161.75 | 125.10 | 128.09 | 136.18 | 66.86 | 111.99 | 91.50 | 134.87 | 100.83 | 81.77 | 100.87 |
Working Capital Days | 92.89 | 102.36 | 87.31 | 92.56 | 104.90 | 82.72 | 145.08 | 136.38 | 122.10 | 103.95 | 63.08 | 104.31 |
ROCE % | 16.98% | 12.44% | 18.13% | 19.19% | 20.80% | 16.37% | 12.08% | 6.39% | 2.38% | 5.84% | 13.88% | 14.73% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 1d
- Compliance Certificate As per Regulation 40(10) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March 2024 13 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for 4th quarter ended on 31st March 2024 of FY 2023-24
- Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations 2015 For The Year Ended On 31St March 2024 8 Apr
- Closure of Trading Window 28 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Concalls
-
Nov 2018TranscriptNotesPPT
-
Sep 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Dec 2017TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Aug 2016TranscriptNotesPPT
-
May 2016TranscriptNotesPPT
-
Mar 2016TranscriptNotesPPT
Business Overview:[1]
Company is the second-largest manufacturer of Empty Hard Shell Gelatin Capsules in India which its sells under the brand name Sunloc. Company does production of double lock, triple lock, multiple groove capsules of EHGC & some proportion of vegan HPMC (Hydroxy Propyl Methyl Cellulose) along with liner, circular, two color printing & 360degree printing being offered